Renalytix AI plc (RENX) ORD GBP0.01 REG S
Share news, reports & tips
20 April 2021 13:48
(Sharecast News) - Renalytix AI announced the findings of a new study in which the commercially-available 'KidneyIntelX' test accurately predicted the progression of diabetic kidney disease (DKD)...
14 April 2021 09:02
(Sharecast News) - Renalytix AI has entered into an exclusive option agreement with Joslin Diabetes Center for patent filings on additional novel biomarkers in kidney disease, it announced on Wednesday, for...
8 April 2021 08:20
(Sharecast News) - Renalytix AI announced findings presented in a late-breaking presentation at the National Kidney Foundation's 2021 Spring Clinical Meetings on Thursday, titled 'Clinical Utility...
6 April 2021 11:08
(Sharecast News) - Renalytix AI reported on Tuesday that its 'KidneyIntelX' product more accurately predicted progressive kidney function decline and kidney failure in a multi-centre, diverse...
15 March 2021 08:55
(Sharecast News) - Artificial intelligence (AI) diagnostics company Renalytix AI updated the market on the establishment of the 'Medicare Coverage of Innovative Technology' (MCIT) pathway on...
2 March 2021 10:39
(Sharecast News) - Artificial intelligence (AI) diagnostics company Renalytix AI recorded $0.4m (£0.29m) of pharmaceutical services revenue in its first half, it announced on Tuesday.
24 February 2021 11:28
(Sharecast News) - Artificial intelligence (AI) diagnostics company Renalytix AI announced a partnership with the University of Utah on Wednesday, to improve kidney health and reduce the risk of kidney...
5 January 2021 09:31
(Sharecast News) - Artificial intelligence (AI) diagnostics company Renalytix AI announced on Tuesday that it was partnering with DaVita on a programme aimed at slowing disease progression and improving...
18 September 2020 12:49
(Sharecast News) - Artificial intelligence kidney diagnostics technology company Renalytix AI announced the commercial launch of its 'KidneyIntelX' clinical test reporting platform within the Mount...
21 August 2020 08:08
(Sharecast News) - Artificial intelligence diagnostics company Renalytix AI revealed on Friday that it will collaborate with pharmaceutical giant AstraZeneca to help improve outcomes for patients with...
12 June 2020 12:33
(Sharecast News) - Artificial intelligence (AI) in vitro diagnostics company Renalytix AI has received a clinical laboratory permit from the New York State Department of Health (NYS DOH) to provide...
10 June 2020 09:26
(Sharecast News) - Artificial intelligence (AI)-focussed diagnostics company Renalytix AI revealed more details of results from a multi-centre clinical validation of 'KidneyIntelX' on Wednesday,...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.